Signed a definitive agreement to acquire dermatology and oral solids businesses from Sandoz Inc., USA.
Signed a definitive agreement to acquire Apotex Inc’s commercial operations in 5 European countries.
Started filing Oncology & Hormones, Dermatology and Nasal ANDAs in US.
Acquired Generis in Portugal - Focus on differentiated technology platforms and Specialty Pharmaceuticals.
Acquired four cell-culture derived biosimilar products from TL Biopharmaceutical AG.

DELIVERING SUSTAINED GROWTH